Alan Nguyen, Michelot Michel, Shane Shahrestani, Andre Boyke, Catherine M Garcia, Simon Menaker, Moise Danielpour, David Bonda
{"title":"Utility of Combining Frailty and Comorbid Disease Indices to Better Predict Outcomes Following Craniotomy for Pediatric Primary Brain Tumors.","authors":"Alan Nguyen, Michelot Michel, Shane Shahrestani, Andre Boyke, Catherine M Garcia, Simon Menaker, Moise Danielpour, David Bonda","doi":"10.1159/000548771","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>There are no predictive outcome scales that have been validated in pediatric patients with brain tumors. An index can help identify children with increased risk for negative postoperative results. The Johns Hopkins Adjusted Clinical Groups (JHACG) frailty and the Elixhauser Comorbidity Index (ECI) have been used independently in adult brain tumor patients to identify patients at increased risk for detrimental outcomes. We investigated whether JHACG and ECI can better predict hospital length of stay (LOS), non-routine discharge, and one-year readmission in pediatric patients undergoing craniotomy for primary brain tumors.</p><p><strong>Methods: </strong>The Nationwide Readmissions Database (NRD) was queried for pediatric brain tumor resections between 2016 and 2019. 237 and 1,235 patients with benign and malignant tumors were identified, respectively. Frailty, ECI, and Frailty+ECI were assessed as predictors using generalized linear mixed-effects models. Receiver operating characteristic (ROC) curves evaluated predictive performance.</p><p><strong>Results: </strong>Frailty+ECI, Frailty, and ECI scores similarly predicted hospital LOS, non-routine discharge, and one-year readmission in the benign tumor cohort. In the malignant cohort, Frailty+ECI (AUC 0.895) outperformed Frailty alone (AUC 0.742, p = 0.001) but performed similarly to ECI score alone (AUC 0.893, p = 0.438) in predicting hospital LOS. Concerning non-routine discharge prediction, Frailty+ECI (AUC 0.871) also outperformed Frailty alone (AUC 0.744, p = 0.04) while performing similarly to ECI score alone (AUC 0.869, p = 0.871). All indices performed similarly to predict one-year readmission in this cohort.</p><p><strong>Conclusion: </strong>Our study demonstrated that Frailty+ECI demonstrated a robust ability to predict hospital LOS and non-routine discharge disposition in pediatric patients undergoing malignant brain tumor resection. These findings suggest that combining these indices may improve the prediction of postoperative outcomes in this population. While further studies are warranted, these findings can be used as a risk assessment index to coordinate care plans with the patient and their family after an operation.</p>","PeriodicalId":54631,"journal":{"name":"Pediatric Neurosurgery","volume":" ","pages":"1-16"},"PeriodicalIF":1.3000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548771","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: There are no predictive outcome scales that have been validated in pediatric patients with brain tumors. An index can help identify children with increased risk for negative postoperative results. The Johns Hopkins Adjusted Clinical Groups (JHACG) frailty and the Elixhauser Comorbidity Index (ECI) have been used independently in adult brain tumor patients to identify patients at increased risk for detrimental outcomes. We investigated whether JHACG and ECI can better predict hospital length of stay (LOS), non-routine discharge, and one-year readmission in pediatric patients undergoing craniotomy for primary brain tumors.
Methods: The Nationwide Readmissions Database (NRD) was queried for pediatric brain tumor resections between 2016 and 2019. 237 and 1,235 patients with benign and malignant tumors were identified, respectively. Frailty, ECI, and Frailty+ECI were assessed as predictors using generalized linear mixed-effects models. Receiver operating characteristic (ROC) curves evaluated predictive performance.
Results: Frailty+ECI, Frailty, and ECI scores similarly predicted hospital LOS, non-routine discharge, and one-year readmission in the benign tumor cohort. In the malignant cohort, Frailty+ECI (AUC 0.895) outperformed Frailty alone (AUC 0.742, p = 0.001) but performed similarly to ECI score alone (AUC 0.893, p = 0.438) in predicting hospital LOS. Concerning non-routine discharge prediction, Frailty+ECI (AUC 0.871) also outperformed Frailty alone (AUC 0.744, p = 0.04) while performing similarly to ECI score alone (AUC 0.869, p = 0.871). All indices performed similarly to predict one-year readmission in this cohort.
Conclusion: Our study demonstrated that Frailty+ECI demonstrated a robust ability to predict hospital LOS and non-routine discharge disposition in pediatric patients undergoing malignant brain tumor resection. These findings suggest that combining these indices may improve the prediction of postoperative outcomes in this population. While further studies are warranted, these findings can be used as a risk assessment index to coordinate care plans with the patient and their family after an operation.
期刊介绍:
Articles in ''Pediatric Neurosurgery'' strives to publish new information and observations in pediatric neurosurgery and the allied fields of neurology, neuroradiology and neuropathology as they relate to the etiology of neurologic diseases and the operative care of affected patients. In addition to experimental and clinical studies, the journal presents critical reviews which provide the reader with an update on selected topics as well as case histories and reports on advances in methodology and technique. This thought-provoking focus encourages dissemination of information from neurosurgeons and neuroscientists around the world that will be of interest to clinicians and researchers concerned with pediatric, congenital, and developmental diseases of the nervous system.